Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Dysfunction”

202 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 202 results

Not applicableStudy completedNCT04694378
What this trial is testing

Relationship Between Strain and Stroke Volume in Cardiac Surgery

Who this might be right for
Right Ventricular DysfunctionStroke Volume IndexLongitudinal Heart Strain
Tufts Medical Center 30
Not applicableStudy completedNCT02979782
What this trial is testing

Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft

Who this might be right for
Postoperative Cognitive DysfunctionCerebrovascular AccidentDelirium
Jessa Hospital 180
Not applicableStudy completedNCT05033236
What this trial is testing

Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)

Who this might be right for
Cardiopulmonary BypassInflammatory ResponsePlatelet Dysfunction
Medical University Innsbruck 190
Not applicableNot Yet RecruitingNCT06604702
What this trial is testing

Fat Injection for Rectocele Treatment: A Novel Approach

Who this might be right for
RectocelePelvic Organ ProlapseObstructive Defecation Syndrome
Cairo University 25
Post-approval studies (Phase 4)Study completedNCT02096107
What this trial is testing

Novartis Everolimus Transition

Who this might be right for
Graft DysfunctionInterstitial Fibrosis
Medical University of South Carolina 60
Not applicableUnknownNCT02826811
What this trial is testing

Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK

Who this might be right for
Graft Dysfunction
University Hospital, Strasbourg, France 170
Not applicableStudy completedNCT04643665
What this trial is testing

Prediction of Pulmonary Graft Dysfunction After Double-lung Transplantation (PGD3-AI Study)

Who this might be right for
Transplant DysfunctionTransplantation, Lung
Hopital Foch 478
Large-scale testing (Phase 3)Ended earlyNCT01564095
What this trial is testing

TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

Who this might be right for
Terminal Liver DiseaseIschemia Reperfusion InjuryGraft Dysfunction+2 more
Ludwig-Maximilians - University of Munich 25
Large-scale testing (Phase 3)UnknownNCT00506532
What this trial is testing

The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study

Who this might be right for
Lung TransplantationPrimary Graft Dysfunction
Rabin Medical Center 42
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableLooking for participantsNCT06743464
What this trial is testing

Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 100
Not applicableNot Yet RecruitingNCT07188064
What this trial is testing

A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery

Who this might be right for
Prostate CancerErectile Dysfunction Following Radical Prostatectomy
Sir Mortimer B. Davis - Jewish General Hospital 100
Not applicableStudy completedNCT02059512
What this trial is testing

Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease

Who this might be right for
Ischemic Heart DiseaseBone Marrow CellsCoronary Artery Bypass Grafting (CABG)+1 more
St. Petersburg State Pavlov Medical University 117
Large-scale testing (Phase 3)Study completedNCT02025621
What this trial is testing

Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Who this might be right for
Coronary Artery Bypass GraftingMitral Valve SurgeryLow Cardiac Output Syndrome
Tenax Therapeutics, Inc. 882
Not applicableStudy completedNCT02177981
What this trial is testing

Impact of Remote Ischemic Preconditioning Preceding Coronary Artery Bypass Grafting on Inducing nEuroprotection

Who this might be right for
Brain IschemiaPostoperative Confusion
University of Zagreb 70
Not applicableStudy completedNCT00805571
What this trial is testing

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Dysfunction
Northwell Health 120
Not applicableUnknownNCT01794871
What this trial is testing

The Histological Analysis in Renal Transplantation Patients With Deterioration of Graft Function

Who this might be right for
Chronic Allograft Dysfunction
Shanghai Zhongshan Hospital 100
Not applicableLooking for participantsNCT06797713
What this trial is testing

Effect of Targeted Fluid Therapy on Postoperative Cognitive Dysfunction.

Who this might be right for
Cognitive Dysfunction, Postoperative
TC Erciyes University 60
Not applicableActive Not RecruitingNCT06395259
What this trial is testing

Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation

Who this might be right for
TransplantationAscorbic Acid Deficiency
Policlinico Hospital 40
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Load More Results